Alatrofloxacin mesylate
- Alatrofloxacin mesylate
- 146961-77-5
- 157605-25-9
- Trovan IV
- Alatrofloxacin mesylate [USAN]
- Create:2005-10-11
- Modify:2025-01-04
- alatrofloxacin
- alatrofloxacin mesylate
- CP 116,517
- CP 116517
- CP-116,517
- CP-116517
- Trovan
- Alatrofloxacin mesylate
- 146961-77-5
- 157605-25-9
- Trovan IV
- Alatrofloxacin mesylate [USAN]
- alatrofloxacin mesilate
- DTXSID2057655
- CP-116517-27
- CP-116,517-27
- CP-116
- 2IXX802851
- CP-11651727
- 7-[(1R,5S)-6-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid
- Alatrofloxacin mesylate (USAN)
- Trovan-IV
- Turvel IV
- 7-[(1S,5R)-6-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid
- Trovan preservative free
- UNII-2IXX802851
- 7-((1R,5S,6s)-6-((S)-2-((S)-2-Aminopropionamido)propionamido)-3-azabicyclo(3.1.0)hex-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, monomethanesulfonate
- 7-[(1R,5S,6S)-6-[(S)-2-[(S)-2-Aminopropionamido]propionamido]-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, monomethanesulfonate
- CP 116,517
- SCHEMBL41134
- Trovan preservative free (TN)
- CHEMBL1200498
- DTXCID20820262
- CYETUYYEVKNSHZ-LGOOQLFJSA-N
- GLXC-10933
- Tox21_113889
- AKOS015904299
- ALATROFLOXACIN MESILATE [MART.]
- ALATROFLOXACIN MESYLATE [VANDF]
- ALATROFLOXACIN MESILATE [WHO-DD]
- NCGC00261969-01
- ALATROFLOXACIN MESYLATE [EMA EPAR]
- L-Alanyl-N-(3-(6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthridin-2-yl)-3-azabicyclo(3.1.0)hex-6-yl)-L-alaninamide (1alpha,5alpha,6alpha)-, monomethanesulfonate
- ALATROFLOXACIN MESYLATE [ORANGE BOOK]
- CAS-146961-77-5
- D02470
- CP 116,517-27
- CP-116,517 -27
- J-008289
- Q27254794
- 7-((1R,5S,6S)-6-((S)-2-((S)-2-aminopropanamido)propanamido)-3-azabicyclo[3.1.0]hexan-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid--methanesulfonic acid (1/1)
- 7-((1R,5S,6S)-6-((S)-2-((S)-2-AMINOPROPIONAMIDO)PROPIONAMIDO)-3-AZABICYCLO(3.1.0)HEX-3-YL)-1-(2,4-DIFLUOROPHENYL)-6-FLUORO-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, MONOMETHANESULPHONATE
- L-ALANINAMIDE, L-ALANYL-N-((1.ALPHA.,5.ALPHA.,6.ALPHA.)-3-(6-CARBOXY-8-(2,4-DIFLUOROPHENYL)-3-FLUORO-5,8-DIHYDRO-5-OXO-1,8-NAPHTHYRIDIN-2-YL)-3-AZABICYCLO(3.1.0)HEX-6-YL)-, METHANESULFONATE (1:1)
- L-Alaninamide, L-alanyl-N-(3-(6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthridin-2-yl)-3-azabicyclo(3.1.0)hex-6-yl)-, (1alpha,5alpha,6alpha)-, monomethanesulfonate
- L-ALANINAMIDE, L-ALANYL-N-(3-(6-CARBOXY-8-(2,4-DIFLUOROPHENYL)-3-FLUORO-5,8-DIHYDRO-5-OXO-1,8-NAPHTHYRIDIN-2-YL)-3-AZABICYCLO(3.1.0)HEX-6-YL)-, MONOMETHANESULFONATE, (1.ALPHA.,5.ALPHA.,6.ALPHA.)
- L-Alaninamide, L-alanyl-N-(3-(6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthyridin-2-yl)-3-azabicyclo(3.1.0)hex-6-yl)-, monomethanesulfonate, (1alpha,5alpha,6alpha)
- L-ALANINAMIDE, L-ALANYL-N-(3-(6-CARBOXY-8-(2,4-DIFLUOROPHENYL)-3-FLUORO-5,8-DIHYDRO-5-OXO-1,8-NAPHTHYRIDIN-2-YL)-3-AZABICYCLO(3.1.0)HEX-6-YL)-, MONOMETHANESULPHONATE, (1.ALPHA.,5.ALPHA.,6.ALPHA.)
M Chen, V Vijay, Q Shi, Z Liu, H Fang, W Tong. FDA-Approved Drug Labeling for the Study of Drug-Induced Liver Injury, Drug Discovery Today, 16(15-16):697-703, 2011. PMID:21624500 DOI:10.1016/j.drudis.2011.05.007
M Chen, A Suzuki, S Thakkar, K Yu, C Hu, W Tong. DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov Today 2016, 21(4): 648-653. PMID:26948801 DOI:10.1016/j.drudis.2016.02.015
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=CYETUYYEVKNSHZ-RSUMCGCKSA-N
- ChEMBLLICENSEAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).http://www.ebi.ac.uk/Information/termsofuse.html
- ChemIDplusAlatrofloxacin mesylate [USAN]https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0146961775ChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- EPA DSSToxAlatrofloxacin mesylatehttps://comptox.epa.gov/dashboard/DTXSID2057655CompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingALATROFLOXACIN MESYLATEhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/2IXX802851
- Drug Induced Liver Injury Rank (DILIrank) DatasetLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- Open TargetsLICENSEDatasets generated by the Open Targets Platform are freely available for download.https://platform-docs.opentargets.org/licenceALATROFLOXACIN MESYLATEhttps://platform.opentargets.org/drug/CHEMBL1200498
- Therapeutic Target Database (TTD)Alatrofloxacin mesylatehttps://idrblab.net/ttd/data/drug/details/D01MGA
- Springer Nature
- Thieme ChemistryLICENSEThe Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc-nd/4.0/
- PubChem
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.htmlalatrofloxacinhttps://www.ncbi.nlm.nih.gov/mesh/67106856Anti-Infective Agentshttps://www.ncbi.nlm.nih.gov/mesh/68000890Topoisomerase II Inhibitorshttps://www.ncbi.nlm.nih.gov/mesh/68059005
- KEGGLICENSEAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial licensehttps://www.kegg.jp/kegg/legal.htmlAntiinfectiveshttp://www.genome.jp/kegg-bin/get_htext?br08307.keg
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseNCI Thesaurushttps://ncit.nci.nih.gov
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 389315419https://pubchem.ncbi.nlm.nih.gov/substance/389315419